Tools
Stock profile

3M CO (MMM)

MMM · Latest close $181.05 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$181.05
As of Nov 18, 2026
Tracked funds holding
6 of 149
2026 Q2 13F filings
Opened / added
0 / 0
vs previous quarter
Trimmed / exited
4
vs previous quarter

3M CO (MMM) is held by 6 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 4 funds trimming or exiting versus the previous quarter. 0 members of Congress reported 0 purchases vs 1 sale. Latest close $181.05 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Congress
0 buys vs 1 sale
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Mairs & Power Funds · Flossbach von Storch · Edgewood Management — 6 tracked funds hold MMM. See all holders.

Insider and Congress activity

0 members of Congress reported buying (0 purchases vs 1 sale). Politician trading

Often held alongside

GENERAL MILLS INC (GIS) · CINTAS CORP (CTAS) · AMGEN INC (AMGN) · GILEAD SCIENCES, INC. (GILD) · ABBOTT LABORATORIES (ABT) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Mairs & Power Funds0.52%349,350TRIMMED (-0.7%) Q3 filed Nov 16
Flossbach von Storch0.34%459,784TRIMMED (-19.3%) Q3 filed Oct 28
Edgewood Management0.13%80,576TRIMMED (-3.6%) Q3 filed Nov 12
Jensen Investment Management0.11%27,618HELD Q3 filed Nov 10
Torray Investment Partners LLC0.04%2,000HELD Q3 filed Oct 30
Dodge & Cox Funds<0.01%7,558TRIMMED (-1.5%) Q3 filed Nov 13

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: +13.1% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

193.95122.792024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

172016Q3: 16 funds2017Q3: 16 funds2018Q1: 17 funds2018Q2: 17 funds2018Q3: 17 funds2019Q1: 16 funds2019Q2: 16 funds2020Q1: 16 funds2016Q32020Q1

Tracked funds holding this stock, by quarter (2016Q3–2020Q1, 8 quarters). Source: quarterly BEST lists from 13F filings — tracked funds only, not all filers. A stock appears here only if it ever made a quarterly BEST list.

All institutions · Form 13F

Institutions holding2,205 of 8,857 filers
Long-only filers among them2,200
Change vs 2026 Q1+95 net · 1,658 entered · 1,563 exited
Shares reported, all filers382,079,546
Reported value, all filers$62.6B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNYSE
IndustrySurgical & Medical Instruments & Apparatus (SIC 3841)
Revenue · FY2025$24.9B
Net income · FY2025$3.2B
Total assets · FY2025$37.7B
Shares outstanding516,729,574
Market cap (at latest close)$93.6B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Sep 30, 2026.

Short interest

Shares short · Oct 15, 202610,033,780
Share of shares outstanding1.94%
Days to cover3.66

Shares short at recent settlements — Jul 31, 2026: 9.9M · Aug 14, 2026: 9.6M · Aug 31, 2026: 9.2M · Sep 15, 2026: 10.0M · Sep 30, 2026: 9.7M · Oct 15, 2026: 10.0M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Sep 30, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Sep 30, 2026.

Insider trading · Form 4

Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Aug 5, 2026Chavez Rodriguez Beatriz KarinaOfficer3,635$663.4KAug 5, 2026SEC filing
Jul 23, 2026Reinseth Theresa EOfficer924$156.5KJul 23, 2026SEC filing
Jul 23, 2026Banovetz John PatrickOfficer7,880$1.3MJul 23, 2026SEC filing
Jul 22, 2026Goralski Christian T JROfficer4,902$835.6KJul 22, 2026SEC filing
Jul 22, 2026Rhodes Kevin HOfficer7,669$1.3MJul 22, 2026SEC filing
Jun 10, 2026Murphy Mark W.Former Officer5,078$808.0KJun 10, 2026SEC filing
Jun 9, 2026Dickson Zoe LFormer Officer5,438$849.5KJun 9, 2026SEC filing
Feb 12, 2026Clarke VictoriaFormer Officer1,041$179.8KFeb 12, 2026SEC filing
Feb 11, 2026Reinseth Theresa EOfficer5,145$888.8KFeb 11, 2026SEC filing
Feb 9, 2026Chavez Rodriguez Beatriz KarinaOfficer1,190$203.6KFeb 9, 2026SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Jul 27, 2026JPMORGAN CHASE & CO.SC 13G/A38,598,1067.4%Jun 30, 2026SEC filing
May 12, 2026JPMORGAN CHASE & COSC 13G/A46,215,3778.8%Mar 31, 2026SEC filing
May 11, 2026SC 13G/A———SEC filing
May 11, 2026SC 13G/A———SEC filing
May 8, 2026SC 13G/A———SEC filing
May 4, 2026SC 13G/A———SEC filing
Apr 27, 2026Vanguard Capital ManagementSC 13G39,527,3167.6%Mar 31, 2026SEC filing
Apr 27, 2026BlackRock, Inc.SC 13G/A34,291,5376.6%Mar 31, 2026SEC filing
Mar 26, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Jul 30, 2025JPMORGAN CHASE & CO.SC 13G40,578,8207.6%Jun 30, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

0 members of Congress reported buying (0 purchases vs 1 sale).

Source: U.S. House Clerk and U.S. Senate eFD STOCK Act periodic transaction reports, as of Nov 16, 2026. Reported amounts are ranges, and reports can arrive up to 45 days after the trade.

Recent activity by member

MemberChamberPartyBuysSellsLatestAmount range
Gottheimer, JoshHouseD01Apr 28, 2026$1,001 - $15,000

Member-level activity in the current window, most recent first (House data to Nov 16, 2026, Senate to Oct 1, 2026). House reports arrive as PDFs without transaction-level rows in the current corpus, so this table shows per-member totals, not individual trades; the member page lists the underlying filings. Senate rows link the same way — the member page carries the eFD filing links.

Committee jurisdiction

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.

None of the members who traded this stock in the current window sit on these committees.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Government relations

Lobbying: no Lobbying Disclosure Act filings matched for this ticker (1999–2026).

Federal contracts: $547.2M in obligated amounts, fiscal years 2021–2026.

Fiscal yearObligated amount
FY2021$123.4M
FY2022$79.8M
FY2023$97.6M
FY2024$110.1M
FY2025$87.6M
FY2026$48.8M

Largest awards collected

Award IDAgencyAmountStart
75A50120C00030Department of Health and Human Services$172.8MMar 21, 2020
FA863820C0046Department of Defense$125.4MMay 1, 2020
W91CRB13C0046Department of Defense$74.4MSep 2, 2013
70FA3020F00000335Department of Homeland Security$44.5MApr 25, 2020
36C77620C0032Department of Veterans Affairs$33.0MJun 11, 2020

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

Financial Screens

· Buffett — Companies with high ROE sustained for more than a decade

· Shareholder Yield — Cash returned through dividends and buybacks

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

· Top Relative Strength — Top 20% of the universe by 6-month return

Key figures

· Buffett — Latest ROE: 68.5% · Years ROE ≥15% (of 10): 9 · 10-yr avg ROE: 34.2% · Latest net income: $3.2B

· Shareholder Yield — Shareholder yield: 5.0% · of which dividends: 1.6% · of which buybacks: 3.4%

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Super-investor 13F BEST — appeared in 8 of the last 40 quarterly lists; latest 2020 Q1, ranked #49 of 50.

· Politician BEST — appeared in 1 of the last 20 quarterly lists; latest 2025 Q1, ranked #37 of 50.

13F signal (2021 Q3 – 2026 Q1)EventsWin rateAvg returnSPYExcess
Heavy accumulation — 3+ tracked funds increased together771.4%+5.9%+4.7%+1.2%

Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.

Also held by the tracked funds that hold MMM — ranked by lift, the co-holding pattern described in Methodology: GENERAL MILLS INC (GIS) · CINTAS CORP (CTAS) · AMGEN INC (AMGN) · GILEAD SCIENCES, INC. (GILD) · ABBOTT LABORATORIES (ABT) · AUTOMATIC DATA PROCESSING INC (ADP) · BIOMARIN PHARMACEUTICAL INC (BMRN) · Blackstone Inc. (BX).

Recent 8-K filings

FiledItemsSource
Nov 4, 20261.01 Entry into a Material Definitive Agreement · 8.01 Other Events · 9.01 Financial Statements and ExhibitsSEC filing
Oct 20, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Oct 19, 20267.01 Regulation FD DisclosureSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

GENERAL MILLS INC (GIS) · Track Record: how the signals scored · Practice timing on MMM

One email a week: the week’s new filings and research. Subscribe free

← MMI  ·  MMS →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.